3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Endometrial Neoplasms
2
Breast Neoplasms
2
TP53 Y220C Mutation
1
Smoking
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Peripheral Nervous System Diseases
1
Overweight
1
Obesity
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Mantle-Cell
1
Localized Prostate Cancer
1
Leukemia, Myeloid, Acute
1
Infertility
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Genetic Diseases, Inborn
1
Cognitive Dysfunction
1
Interventions
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Epirubicin
2
pembrolizumab
1
lenvatinib
1
enfortumab vedotin
1
anlotinib
1
amivantamab
1
Pemetrexed
1
Observation
1
Ipilimumab
1
Imatinib Mesylate
1
Glutamate Carboxypeptidase II
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
BMS-906024
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
Tablets
×
90 days
×
Clear all
No trials found.